Structural and mechanistic features of protein O glycosylation linked to CD8+ T-cell apoptosis

Mol Cell Biol. 2007 Feb;27(3):1096-111. doi: 10.1128/MCB.01750-06. Epub 2006 Nov 13.

Abstract

CD8+ T-cell apoptosis is essential for the contraction phase of the immune response, yet the initiating signals and precise pathways involved are unresolved. The ST3Gal-I sialyltransferase is a candidate mechanistic component and catalyzes sialic acid addition to core 1 O-glycans during protein O glycosylation. ST3Gal-I inactivation or enzymatic removal of its product renders CD8+ T cells, but not CD4+ T cells, susceptible to apoptosis by differential cross-linking of O-glycoproteins in the absence of interleukin-2 and T-cell receptor (TCR) signaling. This results in caspase activation, DNA fragmentation, and phosphatidylserine externalization prior to cell death. We further show that ST3Gal-I function is regulated by a posttranscriptional mechanism operating distal to Golgi core 2 O glycosylation and is invariably linked to CD8+ T-cell contraction following viral (lymphocytic choriomeningitis virus) infection and bacterial (staphylococcal enterotoxin B) antigen immunization. The mechanism does not involve the ST3Gal-I substrate CD43 or core 2 O-glycan induction and overcomes the ability of Bcl-2 to inhibit the contraction phase in vivo. Loss of ST3Gal-I function further reduces Bim-deficient CD8+ T-cell accumulation without diminishing apoptotic sensitivity. We propose that an endogenous lectin activates an apoptotic pathway constructed in CD8+ T cells following TCR stimulation and enables contraction upon attenuation of immune signaling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Annexin A5 / metabolism
  • Antigens, Bacterial / immunology
  • Apoptosis Regulatory Proteins / metabolism
  • Apoptosis* / drug effects
  • Bcl-2-Like Protein 11
  • CD8-Positive T-Lymphocytes / cytology*
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / metabolism*
  • CD8-Positive T-Lymphocytes / virology
  • Cell Compartmentation / drug effects
  • Cross-Linking Reagents / pharmacology
  • Dose-Response Relationship, Drug
  • Enterotoxins / immunology
  • Gene Expression / drug effects
  • Glycosylation / drug effects
  • Homeostasis / drug effects
  • Humans
  • Immunity / drug effects
  • Immunity / immunology
  • Leukopenia / pathology
  • Lymphocytic choriomeningitis virus / immunology
  • Membrane Proteins / metabolism
  • Mice
  • N-Acetylneuraminic Acid / metabolism
  • Polysaccharides / chemistry
  • Protein Modification, Translational / drug effects
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Secretory Vesicles / metabolism
  • Sialyltransferases / chemistry*
  • Sialyltransferases / deficiency
  • Sialyltransferases / metabolism*
  • Structure-Activity Relationship
  • Transgenes
  • beta-Galactoside alpha-2,3-Sialyltransferase

Substances

  • Annexin A5
  • Antigens, Bacterial
  • Apoptosis Regulatory Proteins
  • BCL2L11 protein, human
  • Bcl-2-Like Protein 11
  • Bcl2l11 protein, mouse
  • Cross-Linking Reagents
  • Enterotoxins
  • Membrane Proteins
  • Polysaccharides
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • enterotoxin B, staphylococcal
  • Sialyltransferases
  • N-Acetylneuraminic Acid
  • beta-Galactoside alpha-2,3-Sialyltransferase